all 13 news articles
28 (UPI) — The US Food and Drug Administration has approved the drug Lamisil in a granular form to treat scalp ringworm in young children. ...
... does not respond to topical treatment, hence the need for a formulation palatable for children. Novartis Pharmaceuticals, who manufacturers Lamisil, ...
Tinae capitis does not generally respond to topical solutions. The FDA has recently approved the medication Lamisil for the treatment of scalp ringworm in ...
It is a persistent and contagious fungal infection that usually does not respond to topical treatment. "Tinea capitis is a persistent infection that is hard ...
The USFDA had asked Novartis to produce a version of a child-friendly type of Lamisil, known commonly as terbinafine hydrochloride Under federal law, ...
FDA had requested Novartis to develop a version of Lamisil known generically as terbinafine hydrochloride, which is palatable to children. ...
Oral terbinafine is approved for treatment of toenail or fingernail fungus caused by susceptible dermatophytes and topical terbinafine is approved in ...
all 9 news articles
The US Food and Drug Administration said it had requested a child-friendly form of Lamisil, known generically as terbinafine hydrochloride, ...